検索
Enliven Therapeutics Inc
ELVNウォッチリストに追加
58.810USD
+0.750+1.29%
終値 08-14 16:00（ET）15分遅れの株価
4.31B時価総額
損失額直近12ヶ月PER
株主
更新時刻: Sun, May 10
更新時刻: Sun, May 10
株主統計
種類
株主統計
株主統計
比率
OrbiMed Advisors, LLC
13.07%
Fidelity Management & Research Company LLC
11.36%
Commodore Capital LP
7.71%
Vestal Point Capital, LP
6.29%
Fairmount Funds Management LLC
6.09%
他の
55.48%
株主統計
株主統計
比率
OrbiMed Advisors, LLC
13.07%
Fidelity Management & Research Company LLC
11.36%
Commodore Capital LP
7.71%
Vestal Point Capital, LP
6.29%
Fairmount Funds Management LLC
6.09%
他の
55.48%
種類
株主統計
比率
Investment Advisor/Hedge Fund
27.26%
Investment Advisor
25.47%
Hedge Fund
24.48%
Private Equity
13.57%
Venture Capital
9.65%
Individual Investor
7.52%
Research Firm
1.28%
Bank and Trust
0.22%
Pension Fund
0.20%
機関投資家保有株
更新時刻: Wed, Apr 1
更新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q1
307
64.93M
106.61%
+111.13K
2025Q4
272
61.24M
108.69%
+16.75K
2025Q3
277
61.22M
110.73%
-393.73K
2025Q2
267
61.46M
92.82%
+10.53M
2025Q1
244
50.77M
106.67%
-1.54M
2024Q4
228
50.41M
102.41%
+2.15M
2024Q3
215
48.25M
108.47%
-410.38K
2024Q2
201
48.86M
98.67%
+5.74M
2024Q1
171
44.61M
88.34%
+3.35M
2023Q4
161
39.15M
98.50%
-34.37K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
OrbiMed Advisors, LLC
7.96M
13.31%
--
--
Dec 31, 2025
Fidelity Management & Research Company LLC
6.92M
11.57%
-20.94K
-0.30%
Dec 31, 2025
Commodore Capital LP
4.69M
7.85%
--
--
Dec 31, 2025
Vestal Point Capital, LP
3.83M
6.4%
+2.67M
+230.17%
Dec 31, 2025
Fairmount Funds Management LLC
3.71M
6.21%
--
--
Dec 31, 2025
Polar Capital LLP
3.51M
5.88%
+418.67K
+13.53%
Dec 31, 2025
VR Adviser, LLC
3.23M
5.4%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.13M
5.23%
+9.79K
+0.31%
Dec 31, 2025
Dalton Barbara J
2.54M
4.24%
+2.54M
--
Jun 30, 2025
Janus Henderson Investors
1.67M
2.8%
-121.86K
-6.79%
Dec 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
State Street SPDR S&P Pharmaceuticals ETF
1.63%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.29%
Tema Oncology ETF
1.15%
Virtus LifeSci Biotech Clinical Trials ETF
0.81%
iShares U.S. Pharmaceuticals ETF
0.38%
iShares Micro-Cap ETF
0.19%
ProShares Ultra Nasdaq Biotechnology
0.16%
Invesco Nasdaq Biotechnology ETF
0.13%
Fidelity Fundamental Small-Mid Cap ETF
0.12%
iShares Biotechnology ETF
0.08%
詳細を見る
State Street SPDR S&P Pharmaceuticals ETF
比率1.63%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
比率1.29%
Tema Oncology ETF
比率1.15%
Virtus LifeSci Biotech Clinical Trials ETF
比率0.81%
iShares U.S. Pharmaceuticals ETF
比率0.38%
iShares Micro-Cap ETF
比率0.19%
ProShares Ultra Nasdaq Biotechnology
比率0.16%
Invesco Nasdaq Biotechnology ETF
比率0.13%
Fidelity Fundamental Small-Mid Cap ETF
比率0.12%
iShares Biotechnology ETF
比率0.08%